Novel venom-based peptides (P13 and its derivative-M6) to maintain self-renewal of human embryonic stem cells by activating FGF and TGFβ signaling pathways.
Rui MaZhili RenBin LiShirley W I SiuGuokai ChenHang Fai KwokPublished in: Stem cell research & therapy (2020)
Taken together, this study is the first research finding on a venom-based peptide that works on the FGF and TGF-β signaling pathways to maintain the self-renewal of hESCs.